25.10.2021 • NewsBioNTechMerck

BioNTech Founders in German Research Hall of Fame

Özlem Türeci and Uğur Şahin, founders and managing board members of Mainz-based BioNTech, were inducted into the Hall of Fame of German Research (Hall of Fame der deutschen Forschung) on Oct. 21. The awards ceremony in Wiesbaden, Germany, was organized by German pharmaceuticals, chemicals and life sciences group Merck together with Manager Magazin.

The principals of the company that developed the first mRNA-based Covid-19 vaccine to be approved by regulatory authorities worldwide have done outstanding research for decades and are true pioneers in medicine, Merck CEO Belén Garijo said at the ceremony. “Based on this technology, she said, “the door to an effective treatment of cancer and to new vaccines for infectious diseases is now wide open. Their work has been indispensable in bringing the Covid-19 pandemic to a halt.”

Author: Dede Williams, Freelance Journalist

 

Özlem Türeci and Uğur Şahin, founders and managing board members of Covid...
Özlem Türeci and Uğur Şahin, founders and managing board members of Covid vaccine maker BioNTech, were inducted into the Hall of Fame of German Research on Oct. 21. The awards were presented by German pharmaceuticals, chemicals and life sciences group Merck and Manager Magazin. (c) Merck Group

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.